ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 135 filers reported holding ANTARES PHARMA INC in Q3 2019. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $513,000 | +15.0% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $446,000 | -2.0% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $455,000 | -16.5% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $545,000 | +6.0% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $514,000 | +3.0% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $499,000 | +47.6% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $338,000 | -1.7% | 125,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $344,000 | +16.6% | 125,000 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $295,000 | -49.8% | 125,000 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $588,000 | +40.7% | 125,000 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $418,000 | +1.7% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $411,000 | +8.4% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $379,000 | +11.5% | 125,000 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $340,000 | -19.0% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $420,000 | +30.0% | 125,000 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $323,000 | +17.5% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $275,000 | +10.4% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $249,000 | -38.5% | 125,000 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $405,000 | +0.5% | 125,000 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $403,000 | +13.5% | 125,000 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $355,000 | +22.0% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $291,000 | +20.2% | 125,000 | -13.2% | 0.00% | 0.0% |
| Q3 2016 | $242,000 | -27.3% | 144,000 | -47.6% | 0.00% | -33.3% |
| Q4 2015 | $333,000 | -28.8% | 275,000 | 0.0% | 0.00% | -25.0% |
| Q3 2015 | $468,000 | -18.2% | 275,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $572,000 | -23.2% | 275,000 | 0.0% | 0.00% | -33.3% |
| Q1 2015 | $745,000 | +5.4% | 275,000 | 0.0% | 0.01% | +20.0% |
| Q4 2014 | $707,000 | +39.4% | 275,000 | -0.7% | 0.01% | +25.0% |
| Q3 2014 | $507,000 | -31.5% | 277,000 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $740,000 | -26.8% | 277,000 | 0.0% | 0.01% | -33.3% |
| Q1 2014 | $1,011,000 | – | 277,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,055,000 | 4.58% |
| Centric Wealth Management | 3,337,449 | $13,717,000 | 3.92% |
| Sargent Investment Group, LLC | 3,599,580 | $14,794,000 | 3.90% |
| Rubric Capital Management LP | 8,722,647 | $35,850,000 | 2.09% |
| PERKINS CAPITAL MANAGEMENT INC | 542,283 | $2,229,000 | 1.29% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $7,809,000 | 1.17% |
| Venator Capital Management Ltd. | 550,000 | $2,624,000 | 0.89% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $493,000 | 0.23% |
| ALGERT GLOBAL LLC | 147,616 | $607,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,130,000 | 0.19% |